Investigation of Preoperative Factors Influencing the Outcome of Motor Deficits in Patients Undergoing Lumbar Microdiskectomy

February 9, 2026 updated by: Aristotle University Of Thessaloniki
Lumbar disc herniations may result in lower limb weakness. In such cases, there is a strong indication for surgical intervention through microdiscectomy. This clinical study aims to investigate preoperative factors that may influence the postoperative outcomes of patients undergoing this procedure.

Study Overview

Detailed Description

Background: Motor deficits owing to neural compression caused by lumbar disc herniation are a common problem encountered in spine surgery. Microdiscectomy is considered the preferred procedure for the treatment of limb paresis related to a herniated disc. Nevertheless, there is a restricted number of clinical studies in the literature investigating the role of preoperative factors that could influence the postoperative outcome in these patients.

Aim: To investigate the prognostic factors determining the outcome in patients with lower limb paresis caused by a herniated lumbar disc subjected to microdiscektomy.

Study type: Primary clinical research, observational prognostic study. Materials: Patients suffering from a motor deficit due to lumbar disc herniation to undergo lumbar microdiscectomy in three neurosurgical departments.

Protocol: Prospective multicenter study. This research will discover the prognostic value of two primary and five secondary preoperative factors. Primary factors: a) the severity of paresis, b) the duration of paresis. Secondary factors: a) age, b) body mass index, c) diabetes mellitus, d) anatomic location of the herniated disc, e) morphology of the herniated disc.

Outcomes: The key evaluation criterion is the muscle strength of the most severely affected lower limb muscle according to the six-point (0-5) Medical Research Counsil (MRC) Scale for Muscle Strength. After the comparison between the postoperative and preoperative muscle strength, the outcome of paresis will be recorded as: a) full recovery, b) partial recovery or c) no recovery.

Sample size: Forty (40) patients.

Study Type

Observational

Enrollment (Estimated)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Kavala, Greece, 65500
        • Recruiting
        • General Hospital of Kavala
        • Contact:
        • Principal Investigator:
          • Panagiotis Sarlis, MSc, MD
        • Sub-Investigator:
          • Stavros Stamatiou
        • Sub-Investigator:
          • Georgios Kalostos
      • Thessaloniki, Greece, 57001
        • Recruiting
        • European Interbalkan Medical Center
        • Contact:
        • Principal Investigator:
          • Alkinoos Athanasiou
        • Sub-Investigator:
          • Georgios Psychidis
        • Sub-Investigator:
          • Georgios Antonoglou
      • Thessaloniki, Greece, 54642
        • Recruiting
        • Hippokration General Hospital
        • Contact:
        • Principal Investigator:
          • Ioannis Magras, Professor
        • Sub-Investigator:
          • Parmenion Tsitsopoulos, Professor
        • Sub-Investigator:
          • Elias Antoniades
        • Sub-Investigator:
          • Emmanouil Kenanoglou
        • Sub-Investigator:
          • Panagiotis Kartsidis

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients visiting the three recruitment hospitals, all located in North Greece.

Description

Inclusion Criteria:

  • Patients suffering from lower limb paresis (motor deficit) caused by lumbar disk herniation undergoing a single-level microdiskectomy
  • Age (years) > 17

Exclusion Criteria:

  • Age (years) < 18
  • Medical history of lumbar spine surgery
  • Absence of limb paresis
  • Motor deficit caused by other than disk herniation aetiologies
  • Reoperation within 6 months after microdiskectomy
  • Microdiskectomy at more than one level
  • Cauda equina syndrome
  • Peripheral neuropathy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Patients with limb paresis due to lumbar disk herniation undergoing microdiskectomy
Patients suffering from motor deficit because of lumbar disk herniation scheduled to undergo single-level microdiskectomy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle Strength
Time Frame: Perioperative
The strength of lower main muscles will be assessed and will be rated according to the Medical Research Council Scale for Muscle Strength. The scale takes values between 0 and 5, with 5 being the best possible (healthy).
Perioperative
Duration of paresis before surgical treatment
Time Frame: Baseline
Time between the initiation of paresis and surgical treatment measured in days
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Age
Time Frame: Baseline
The age of participant as measured in years
Baseline
Obesity
Time Frame: Baseline
Body Mass Index (BMI) measured as the ratio between the mass measured in kilograms over the square of height measured in meters. There will be two groups of patients: a) with obesity and b) without obesity.
Baseline
Diabetes Melitus
Time Frame: Baseline
Participant is diagnosed with diabetes melitus (yes/no)
Baseline
Hernia location
Time Frame: Baseline
Categorisation of hernia location based on Magnetic Resonance Imaging (MRI) to a) central, b) subarticular, c) foraminal, and d) extra-foraminal.
Baseline
Hernia morphology
Time Frame: Baseline
Hernia morphology will be categorised based on radiology images to a) central, b) extrusion and c) sequestation.
Baseline
Level of Pain
Time Frame: Perioperative
The pain level of participants will be measured using the Numeric Rating Scale for Pain which ranges from 0 (no pain) to 10 (worst pain imaginable).
Perioperative
Functionality
Time Frame: Perioperative
The functionality of participants will be measured using the Oswestry Disability Index (ODI) which consists of 10 questions using a 5-level Likert scale with 0 being the best.
Perioperative
Quality of life assessment
Time Frame: Perioperative
This outcome will be measured using the EQ-5D-5L questionnaire. It is using 5-Level Likert scale, with 0 being the best. Also, it includes a self-report of health status using a 0 to 100 scale, 100 being best.
Perioperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Panagiotis Sarlis, Aristotle University Of Thessaloniki

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 3, 2024

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

January 24, 2026

First Submitted That Met QC Criteria

February 9, 2026

First Posted (Actual)

February 17, 2026

Study Record Updates

Last Update Posted (Actual)

February 17, 2026

Last Update Submitted That Met QC Criteria

February 9, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Muscle Weakness

Subscribe